CLINICAL TRIALS PROFILE FOR LABETALOL HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for LABETALOL HYDROCHLORIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000291 ↗ | Effects of Labetalol on Human Cocaine Use - 8 | Completed | University of Minnesota | Phase 2 | 1997-10-01 | The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine. |
NCT00000291 ↗ | Effects of Labetalol on Human Cocaine Use - 8 | Completed | University of Minnesota - Clinical and Translational Science Institute | Phase 2 | 1997-10-01 | The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine. |
NCT00000291 ↗ | Effects of Labetalol on Human Cocaine Use - 8 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 1997-10-01 | The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine. |
NCT00000297 ↗ | Effects of Labetalol on Nicotine Administration in Humans - 14 | Completed | University of Minnesota | Phase 2 | 1998-10-01 | The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LABETALOL HYDROCHLORIDE
Condition Name
Clinical Trial Locations for LABETALOL HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for LABETALOL HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for LABETALOL HYDROCHLORIDE
Sponsor Name